Veon (VEON) EBITDA (2009 - 2026)

Veon has reported EBITDA for 17 years, with the latest figure at $517.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 17.77% year-over-year to $517.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (up 66.05% YoY), and the FY2025 full-year result was $2.0 billion, up 23.06% from the prior year.
• EBITDA for Q1 2026 stood at $517.0 million, down from $820.0 million in the prior quarter.
• The five-year high for EBITDA was $820.0 million in Q2 2025, with the low at $225.0 million in Q2 2022.
• Historically, EBITDA has averaged $406.8 million across 5 years, with a median of $358.5 million in 2024.
• The largest YoY upside for EBITDA was 537.5% in 2022 against a maximum downside of 36.62% in 2022.
• Veon's EBITDA stood at $455.0 million in 2022, then plunged by 46.81% to $242.0 million in 2023, then grew by 14.88% to $278.0 million in 2024, then surged by 194.96% to $820.0 million in 2025, then sank by 36.95% to $517.0 million in 2026.
• The last three EBITDA figures came in at $517.0 million (Q1 2026), $820.0 million (Q2 2025), and $439.0 million (Q1 2025), per Business Quant data.